CHINWAGYThe world's live brand collaboration wire
Join freeCreatorsIndustryContact
For you +
ReadersCreatorsBrands & IndustryContact Chinwagy

THE CHINWAGY BUZZ · FIRST VERIFIED WORD

Novo Nordisk and United Biotechnology Advance Jointly Developed Triple Agonist

Novo Nordisk×The United Laboratories International Holdings Limited×United Biotechnology
Official image for Novo Nordisk and United Biotechnology Advance Jointly Developed Triple Agonist
Official collaboration image · verified from the named source

WHAT CHINWAGY KNOWS

The collaboration
is confirmed.

United Biotechnology and Novo Nordisk reported phase 2 results for UBT251, a triple agonist jointly developed under an agreement signed in March 2025.

Current status
Official collaboration
Known availability
The official source confirms the collaboration; timing details remain under review.
Place
Guangdong, China
Source checked
September 16, 2026

SHARE OR FOLLOW THE BUZZ

Keep it moving.

Share the permanent Chinwagy profile, download a branded social card or save the story so its next update stays within reach.

FOLLOW THE STORY

More details will move this intelligence into the right Chinwagy destination.